Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond

COVID-19 and Nicotine as a Mediator of ACE-2

(2020) Janice M. Leung et al.   EUROPEAN RESPIRATORY JOURNAL

Response to Commentary on “The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients”

(2020) Yan-Chao Li et al.   JOURNAL OF MEDICAL VIROLOGY

Memantine can relieve the neuronal impairment caused by neurotropic virus infection

(2019) Leqiang Sun et al.   JOURNAL OF MEDICAL VIROLOGY

Memantine ameliorates pulmonary inflammation in a mice model of COPD induced by cigarette smoke combined with LPS

(2018) Qingmei Cheng et al.   BIOMEDICINE & PHARMACOTHERAPY

Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli–Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses

(2015) Jing-Yi Yu et al.   PLoS One

Novel Treatment with Neuroprotective and Antiviral Properties against a Neuroinvasive Human Respiratory Virus

(2013) E. Brison et al.   JOURNAL OF VIROLOGY

Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination

(2010) Hélène Jacomy et al.   JOURNAL OF NEUROVIROLOGY

Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation

(2009) Hung-Ming Wu et al.   NEUROPSYCHOPHARMACOLOGY